R. E. Bristow, F. J. Montz, L. D. Lagasse, R. S. Leuchter and B. Y. Karlan, “Survival Impact of Cytoreduction in Stage IV Epithelian Ovarian Cancer,” Gynecologic Oncology, Vol. 72, No. 3, 1999, pp. 278-287. doi:10.1006/gyno.1998.5145

has been cited by the following article:

• TITLE: Liver Metastases from Gynecological Cancers: Time to Resection?

  AUTHORS: Jose M. Ramia, Roberto De La Plaza, Jose Quiñones, Pilar Veguillas, Farah Adel, Jorge García-Parreño

  KEYWORDS: Liver; Metastasis; Gynecology; Ovary; Cancer; Review

  JOURNAL NAME: Surgical Science, Vol.3 No.3, March 23, 2012

  ABSTRACT: Aim: To perform an update of liver resection as treatment of liver metastases of gynecological cancers, as well as an update on these metastases. Bibliographical search: PubMed Search 1990-2011 in English language. Authors reviewed only relevant articles. Results: No more than 20 relevant articles have been published on this topic, including case reports. We performed a classical review of the information published in the literature. Conclusions: Liver Metastases from Gynecological cancers, not peritoneal implants in the liver, usually appear in patients with disseminated disease, so it is uncommon to perform a liver resection. In some patients with limited extrahepatic disease or only liver disease, liver resection is a safe alternative and improves the oncological results. We try to emphasize which patients may benefit from liver resection and the importance of tailoring medical decisions.